within your practice.

Easy to start.

A non-fasting and simple blood test is all it takes to risk stratify your patient base.

Easy to find out who
needs more or less attention.

The KidneyIntelX test provides a highly-reliable, meaningful risk score and the confidence to know whether your patient is at low, intermediate or high risk for progression.

Easy to know what to do next.

Each risk score test report is very simple to understand and comes with a suggested patient-specific, actionable care path based on guideline recommendations.

Simple to order

Experienced Medical Affairs Team on call.

Renalytix, the founder of KidneyIntelX, understands the importance of clinical support and information exchange. That’s why, we are committed to providing a fully staffed Medical Affairs Team who can educate regarding our proprietary methodology, evidential studies, test protocol, patient results, and pharmacy management.

Small changes can yield big results.

Until recently, available chronic kidney disease drugs were insufficient, and significant disease progression still occurred in clinical trials and in clinical practice.

There are now effective therapeutics available that could save lives and prevent kidney failure and cardiovascular complications, which is the major cause of death in these patients.

Clinicians can also communicate that there are proven ways to help improve outcomes and quality of life for some patients.

That’s why small changes can yield meaningful results in chronic disease management. By leveraging the insights KidneyIntelX provides with available pharmacy resources, clinicians can match the patient’s risk with the therapeutics employed.

Are the therapeutics you’re using now…optimized?